Risperidone  Oral Solution

1 mg/ml (30 ml)

central nervous system


Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders.
Unipharm’s generic Risperidone Oral Solution has been manufactured and marketed in Israel since 2009.

  • ATC4: N05AX
  • Strengths: 1 mg/ml (30 ml)
  • Dosage forms: Oral Solution and Tablets (1, 2, 3 & 4 mg)
  • Out-licensing is offered for all international markets*
* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products